Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wayne Furman

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumorsCarlos Rodriguez-Galindo, Kristine R Crews, Clinton F Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?John T Lucas, M Beth McCarville, David A Cooper, et al.
Pediatric Pulmonology|September 29, 2021
Interstitial lung disease in children with Rubinstein-Taybi syndromeLauren Bradford, Mindy K Ross, Jagila Minso, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cancer Chemotherapy and Pharmacology|July 8, 2005
Phase I study of the combination of topotecan and irinotecan in children with refractory solid tumorsCarlos Rodriguez-Galindo, Kristine R Crews, Clinton F Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|November 30, 2018
Implications of Image-Defined Risk Factors and Primary-Site Response on Local Control and Radiation Treatment Delivery in the Management of High-Risk Neuroblastoma: Is There a Role for De-escalation of Adjuvant Primary-Site Radiation Therapy?John T Lucas, M Beth McCarville, David A Cooper, et al.
Pediatric Pulmonology|September 29, 2021
Interstitial lung disease in children with Rubinstein-Taybi syndromeLauren Bradford, Mindy K Ross, Jagila Minso, et al.
Molecular Oncology|February 25, 2014
Validation of a prognostic multi-gene signature in high-risk neuroblastoma using the high throughput digital NanoString nCounter™ systemThomas P Stricker, Andres Morales La Madrid, Alexandre Chlenski, et al.
Pageof 2